IPC분류정보
국가/구분 |
United States(US) Patent
공개
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0280140
(2011-10-24)
|
공개번호 |
US-0105470
(2012-05-03)
|
우선권정보 |
JP-JP 2010-240856 (2010-10-27) |
발명자
/ 주소 |
|
출원인 / 주소 |
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
0 |
초록
▼
A method for displaying HbA1c measurement results is provided, which makes it possible to prevent overlooking a sample that exhibits an HbA1c value at a predetermined level different from a normal value, for example, a sample that exhibits a diabetic type. The method is a display method for displayi
A method for displaying HbA1c measurement results is provided, which makes it possible to prevent overlooking a sample that exhibits an HbA1c value at a predetermined level different from a normal value, for example, a sample that exhibits a diabetic type. The method is a display method for displaying spectrum data as results of measurement of hemoglobin A1c (HbA1c) in a sample by separation analysis, and the method includes applying one of at least two different types of designs to a peak area for HbA1c in the spectrum data, according to an amount of HbAlc in the sample, or according to the amount of HbA1c and an amount of blood glucose in the sample.
대표청구항
▼
1. A method for displaying spectrum data as a result of measurement of hemoglobin A1c (HbA1c) in a sample by separation analysis, the method comprising: applying one of at least two different types of designs to a peak area for HbA1c in the spectrum data, according to an amount of HbA1c in the sampl
1. A method for displaying spectrum data as a result of measurement of hemoglobin A1c (HbA1c) in a sample by separation analysis, the method comprising: applying one of at least two different types of designs to a peak area for HbA1c in the spectrum data, according to an amount of HbA1c in the sample, or according to the amount of HbA1c and an amount of blood glucose in the sample. 2. The method according to claim 1, wherein the type of the design applied to the peak area for HbA1c is altered with reference to an HbA1c value as diagnostic criteria for diabetes. 3. The method according to claim 1, wherein the type of the design applied to the peak area for HbA1c when the sample exhibits an HbA1c value as the international standard value of 6.5% or more (JDS value: 6.1% or more), and the type of the design applied to the peak area for HbA1c when the sample exhibits an HbA1c value as the international standard value of less than 6.5% (JDS value: less than 6.1%), are different from each other. 4. The method according to claim 1, wherein either a design for a diabetic type or a design for a non-diabetic type is applied to the peak area for HbA1c, with reference to an HbA1c value and a blood glucose value as diagnostic criteria for diabetes. 5. The method according to claim 1, wherein a design for a diabetic type is applied to the peak area for HbA1c, when any one of conditions a) to c) shown below is satisfied: a) fasting blood glucose value≧126 mg/dl, and HbA1c value≧6.5% (international standard value) (JSD value: 6.1%);b) blood glucose value 2 hours after OGTT≧200 mg/dl, and HbA1c value≧6.5% (international standard value) (JSD value: 6.1%); andc) casual blood glucose value≧200 mg/dl, and HbA1c value≧6.5% (international standard value) (JSD value: 6.1%). 6. A device comprising: a measurement section that measures hemoglobin A1c (HbA1c) in a sample by separation analysis and obtains a measured amount of HbA1c and spectrum data;a display data conversion section that applies one of at least two different types of designs to a peak area for HbA1c in the spectrum data according to the amount of HbA1c or according to the amount of HbA1c and an amount of blood glucose; andat least one of a display section that displays display data obtained through the conversion, a printing section that prints out the data, and a transmission section that transmits the data. 7. A device comprising: a reception section that obtains an amount of HbA1c and spectrum data as results of measurement of hemoglobin A1c (HbA1c) in a sample by separation analysis;a display data conversion section that applies one of at least two different types of designs to a peak area for HbA1c in the spectrum data according to the amount of HbA1c or according to the amount of HbA1c and an amount of blood glucose; andat least one of a display section that displays display data obtained through the conversion, a printing section that prints out the data, and a transmission section that transmits the data to outside. 8. The device according to claim 6, wherein the display data conversion section alters the type of the design applied to the peak area for HbA1c, by referring to the HbA1c as the diagnostic criteria for diabetes. 9. The device according to claim 6, wherein the display data conversion section applies different types of the designs to the peak area for HbA1c, respectively, when the sample exhibits an HbA1c value as the international standard value of 6.5% or more (JDS value: 6.1% or more), and when the sample exhibits an HbA1c value as the international standard value of less than 6.5% (JDS value: less than 6.1%). 10. The device according to claim 6, the display data conversion section applies either a design for a diabetic type or a design for a non-diabetic type to the peak area for HbA1c, by referring to an HbA1c value and a blood glucose value as diagnostic criteria for diabetes. 11. The device according to claim 6 wherein the display data conversion section applies a design for a diabetic type to the peak area for HbA1c, when any one of conditions a) to c) shown below is satisfied: a) fasting blood glucose value≧126 mg/dl, and HbA1c value≧6.5% (international standard value) (JSD value: 6.1%);b) blood glucose value 2 hours after OGTT≧200 mg/dl, and HbA1c value≧6.5% (international standard value) (JSD value: 6.1%); andc) casual blood glucose value≧200 mg/dl, and HbA1c value≧6.5% (international standard value) (JSD value: 6.1%). 12. The device according to claim 6, wherein the separation analysis is liquid chromatography, electrophoresis, gas chromatography, or electrochromatography, and the spectrum data are data of a chromatogram or an electropherogram. 13. A non-transitory computer-readable recording medium storing a display program that causes a processor that displays an amount of hemoglobin A1c (HbA1c) and spectrum data obtained by measuring HbA1c in a sample by separation analysis to execute the processes of: making access to a recording section that has preliminarily recorded correspondence relationship data indicating correspondence relationship between either the amount of HbA1c or the amount of HbA1c and an amount of blood glucose on one hand and a design on the other hand, and deciding a design corresponding to either the amount of HbA1c in the sample or the amount of HbA1c and the amount of blood glucose in the sample;altering a design of a peak area for HbA1c in the spectrum data of the sample to the decided design; anddisplaying, printing, or outputting to outside, the spectrum data having the alteration.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.